Fate Therapeutics Inc (NASDAQ:FATE)

6.06
Delayed Data
As of 12:42pm ET
 -0.08 / -1.30%
Today’s Change
3.50
Today|||52-Week Range
8.78
+20.48%
Year-to-Date

Today’s Trading

Previous close6.14
Today’s open6.08
Day’s range5.90 - 6.15
Volume68,808
Average volume (3 months)115,824
Market cap$163.6M
Dividend yield--
Data as of 12:42pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)+64.12%
Earnings growth (this year)-13.12%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book4.46

Competitors

 Today’s
change
Today’s
% change
KMPHKemPharm Inc-0.40-3.38%
IMCLEImmunoClin Corp0.00--
KMDAKamada Ltd+0.05+1.17%
CRMDCorMedix Inc+0.15+2.60%
Data as of 12:56pm ET, 05/27/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$0.00
Annual profit (last year)-$25.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christian Weyer
Chief Financial &
Operating Officer
J. Scott Wolchko
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers